Ardelyx
ARDX
#5303
Rank
โ‚ฌ1.33 B
Marketcap
5,39ย โ‚ฌ
Share price
2.96%
Change (1 day)
46.14%
Change (1 year)

Revenue for Ardelyx (ARDX)

Revenue in 2026 (TTM): โ‚ฌ0.36 Billion

According to Ardelyx's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.36 Billion. In 2025 the company made a revenue of โ‚ฌ0.34 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ0.32 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ardelyx from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.36 B5.29%
2025 โ‚ฌ0.34 B8.15%
2024 โ‚ฌ0.32 B184.76%
2023 โ‚ฌ0.11 B131.54%
2022 โ‚ฌ48.62 M445.38%
2021 โ‚ฌ8.91 M44.84%
2020 โ‚ฌ6.15 M30.57%
2019 โ‚ฌ4.71 M106.87%
2018 โ‚ฌ2.27 M-93.49%
2017 โ‚ฌ35 M
2016 N/A-100%
2015 โ‚ฌ21.97 M-15.49%
2014 โ‚ฌ26 M24.13%
2013 โ‚ฌ20.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Abbott Laboratories
ABT
โ‚ฌ38.80 B 10,453.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ32.00 B 8,602.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ47.68 B 12,867.96%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
โ‚ฌ51.96 B 14,031.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
โ‚ฌ0.55 B 50.13%๐Ÿ‡บ๐Ÿ‡ธ USA